Click Here to Download the Course Flyer
Hepatitis C infections are largely attributable to unsafe injecting drug use practices, with people who inject drugs representing approximately 90% of newly acquired infections. Staff in Drug and Alcohol settings play an important role in improving the health outcomes of people living with Hepatitis C and can reduce a patient’s risk of developing advanced liver disease through early diagnosis, thorough evaluation and assessment of liver disease severity, appropriate management of co-morbidities and treatment with newly available drug regimens.
• Interpret test results and diagnose hepatitis C appropriately
• Ensure that people at risk of hepatitis C infection are regularly screened
• Manage and monitor people with chronic hepatitis C suitably, including staging of liver disease and lifestyle modifications as needed
• Prepare clients for HCV treatment and confidently discuss; adherence; psychosocial issues; the effect of drug and alcohol use on HCV treatment; and liver health
Conditions of registration:
Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before Friday 10 March 2017 will not incur a cancellation fee. Cancellations received in writing after Friday 10 March 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.
As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to firstname.lastname@example.org
For further details contact:
May Wang (Project support officer):
T 02 8204 0723